HTDS Content Services

Exclusive

Category

Source

Publication

Byline

Location

Singapore Clinical Trial: A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects with Moderate-to-Severe Active Thyroid Eye Disease

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, ... Read More

Singapore Clinical Trial: Immunogenicity of Recombinant Zoster Vaccine in Long-term Solid Organ Transplant Recipients

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Immunogenicity of Recombinant Zoster Vaccine in Long-term Solid Organ Transplant Recipients'. The fo... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of... Read More

Singapore Clinical Trial: Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome'. T... Read More

Singapore Clinical Trial: A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy (ACT-EARLY OLE)

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed V... Read More

Singapore Clinical Trial: Healthy longevity with rapamycin (LONGER)

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Healthy longevity with rapamycin (LONGER)'. The following are the other relevant details related to ... Read More

Singapore Clinical Trial: FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma'.... Read More

Singapore Clinical Trial: Efficacy and safety of LUCONAC ® External Solution for the treatment of Onychomycosis in anopen label head-to-head comparison with Amorolfine Nail Lacquer.

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'Efficacy and safety of LUCONAC ® External Solution for the treatment of Onychomycosis in anopen labe... Read More

Singapore Clinical Trial: A multicenter, randomized, participant- and investigator - blinded, placebo-controlled, phase 2a study to assess the efficacy, safety and tolerability of GIA632 in adult participants with moderate to severe atopic dermatitis

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, participant- and investigator - blinded, placebo-controlled, phase 2a stu... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Posted On: 2026-05-01
Health & Lifestyle Health Daily Digest

Singapore, May 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, mul... Read More